IGF2BP3 and rheumatoid arthritis: More importantly, the expression level of IGF2BP3 was robustly decreased in CEL‐treated rats, further suggesting that CEL could also alleviate RA progression by targeting IGF2BP3 in vivo (Figure 3C,D).